Unadjusted Analyses | Adjusted Analyses* | |||||
---|---|---|---|---|---|---|
Factors | Beta | 95% CI | p | Beta | 95% CI | p |
Age | 1.759 | −1.141, 4.66 | 0.229 | 1.140 | −1.437, 3.716 | 0.378 |
Sex | −35.129 | −97.905, 27.647 | 0.267 | −17.011 | −71.823, 37.800 | 0.536 |
Previous DMARD | 104.430 | 55.443, 153.417 | 0.001 | 96.312 | 45.030, 147.594 | 0.001 |
Smoking | −54.005 | −113.383, 5.374 | 0.074 | −9.745 | −66.423, 46.933 | 0.731 |
SGC | −63.936 | −126.441, −1.43 | 0.045 | −57.158 | −112.769, −1.547 | 0.044 |
ACPA | 0.129 | −0.109, 0.367 | 0.281 | – | – | – |
RDD | 5.649 | 2.416, 8.881 | 0.001 | – | – | – |
↵* R2 = 0.342 (adjusted for age, sex, previous use of DMARD, smoking, and SGC). COMP: cartilage oligomeric matrix protein. Previous DMARD: use of disease-modifying antirheumatic drug within the year preceding the study; SGC: systemic glucocorticosteroids; ACPA: anticitrullinated protein antibodies; RDD: rheumatoid disease duration.